Home › Funds › Global Alpha Capital Management Ltd. › GMED

Global Alpha Capital Management Ltd. position in GMED

GLOBUS MED INC · Health Care

Global Alpha Capital Management Ltd. reported holding 499,645 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$37.4M, representing 2.44% of its reported portfolio and ranking #16 among its reported holdings. Global Alpha Capital Management Ltd. has disclosed GMED holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)499.64K sh
Reported value held$37.42M
Portfolio Weight2.44%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Global Alpha Capital Management Ltd.'s GMED position evolved

Global Alpha Capital Management Ltd. first disclosed a stake in GMED in Q3 2023 at 349,261 shares (US$17.3M). The position peaked in Q4 2024 at 819,391 shares, worth US$67.8M. Across 13 filings, Global Alpha Capital Management Ltd. increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 499,645 shares valued at US$37.4M — a reduction of -356,971 shares quarter over quarter.. Notable position changes include a 109% increase in Q4 2023 (shares were roughly flat over the following quarter), a 49% increase in Q2 2025 (shares fell 3% over the following quarter), a 42% trim in Q4 2025 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 349.26K $17.34M New
Q4 2023 728.30K $38.81M Add
Q1 2024 927.74K $49.76M Add
Q2 2024 958.94K $65.68M Add
Q3 2024 885.14K $63.32M Reduce
Q4 2024 819.39K $67.77M Reduce
Q1 2025 707.69K $51.80M Reduce
Q2 2025 1.06M $62.27M Add
Q3 2025 1.15M $65.61M Add
Q4 2025 666.70K $58.21M Reduce
Q1 2026 694.44K $59.83M Add
Q2 2026 856.62K $67.68M Add
Q3 2026 499.64K $37.42M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GMED and 13F data

GMED (GLOBUS MED INC) is a Health Care company. 36 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$123.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GMED

All GMED fund holders →

FAQ

How long has Global Alpha Capital Management Ltd. held GMED?

Global Alpha Capital Management Ltd. has disclosed GMED holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Global Alpha Capital Management Ltd.'s current position in GMED?

As of Q3 2026, Global Alpha Capital Management Ltd. holds 499.64K shares of GMED (GLOBUS MED INC), valued at $37.42M, representing 2.44% of its reported portfolio and ranking #16.

Has Global Alpha Capital Management Ltd. been buying or selling GMED?

In the latest 13F filing (Q3 2026), Global Alpha Capital Management Ltd. reduced its position in GMED. The position peaked in Q4 2024 at 819.39K shares.

Which other funds hold GMED?

Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.